The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.

1990 • 633 citations

Overview of Randomized Trials of Postoperative Adjuvant Radiotherapy in Breast Cancer

1988 • 307 citations

Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen

1981 • 289 citations

The pulmonary toxicity of antineoplastic agents.

1982 • 237 citations

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.

1986 • 215 citations

Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.

1989 • 152 citations

The effect of post-operative radiotherapy in breast cancer

1977 • 148 citations

Radiation-adriamycin interactions: Preliminary clinical observations

1975 • 138 citations

Pulmonary toxicity of antineoplastic agents

1983 • 133 citations

Cyclophosphamide therapy and interstitial pulmonary fibrosis

1976 • 126 citations

Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer

1984 • 115 citations

Pulmonary Toxicity of Antineoplastic Drugs

1981 • 85 citations

Ten-Year Results of FAC Adjuvant Chemotherapy Trial in Breast Cancer

1989 • 81 citations

Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial

1990 • 76 citations

Radiation-Induced Lung Injury

1990 • 69 citations

Adjuvant Treatment of Postmenopausal Patients with High Risk Primary Breast Cancer: Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 C

1988 • 63 citations

Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

1990 • 61 citations

Complications of irradiation related to apparent drug potentiation by adriamycin

1976 • 58 citations

Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer.

1989 • 54 citations

ADJUVANT THERAPY WITH TAMOXIFEN IN OPERABLE BREAST CANCER

1988 • 52 citations

Adjuvant Therapy of Premenopausal and Menopausal High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B

1988 • 46 citations

Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer

1990 • 41 citations

Sixteen-Week Dose-Intense Chemotherapy in the Adjuvant Treatment of Breast Cancer

1990 • 41 citations

West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes

1989 • 35 citations

Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer

1987 • 29 citations

Distant Recurrence in Breast Cancer: Survival expectations and first choice of chemotherapy regimen

1988 • 29 citations

Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre

1988 • 22 citations

Treatment of early breast cancer.

1972 • 22 citations

Randomized Trial Comparing Chemotherapy Alone and Chemotherapy Plus Chest Irradiation in Limited Stage Small Cell Lung Cancer: A Preliminary Report

1986 • 19 citations

Chemotherapy-Associated Pulmonary Toxic Reactions During Treatment for Breast Cancer

1984 • 18 citations

Assessment of tamoxifen as adjuvant therapy in stage II breast cancer: a long-term follow-up.

1987 • 17 citations

A Feasibility Study of Intensive CAF as Outpatient Adjuvant Therapy for Stage II Breast Cancer in a Cooperative Group: CALGB 8443

1990 • 9 citations

The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma

1983 • 7 citations